ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 294 filers reported holding ISIS PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $525,000 | -29.8% | 13,000 | 0.0% | 0.03% | -27.0% |
| Q2 2015 | $748,000 | -9.7% | 13,000 | 0.0% | 0.04% | -5.1% |
| Q1 2015 | $828,000 | +3.1% | 13,000 | 0.0% | 0.04% | +2.6% |
| Q4 2014 | $803,000 | +59.0% | 13,000 | 0.0% | 0.04% | +35.7% |
| Q3 2014 | $505,000 | +22.3% | 13,000 | +8.3% | 0.03% | +21.7% |
| Q2 2014 | $413,000 | – | 12,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,634,838 | $268,180,000 | 8.50% |
| DOWLING & YAHNKE LLC | 676,379 | $27,339,000 | 3.72% |
| WILLIAM HARRIS INVESTORS INC | 317,301 | $12,826,000 | 3.63% |
| Opus Point Partners Management, LLC | 101,401 | $4,099,000 | 2.26% |
| SOUND ENERGY PARTNERS, INC. | 25,000 | $1,011,000 | 2.04% |
| Sonora Investment Management, LLC | 127,104 | $6,622,000 | 2.00% |
| PINNACLE ASSOCIATES LTD | 1,778,325 | $71,880,000 | 1.59% |
| MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ | 17,000 | $687,000 | 1.36% |
| Apex Capital Management | 1,019,618 | $41,213,000 | 0.93% |
| PERKINS CAPITAL MANAGEMENT INC | 20,350 | $823,000 | 0.92% |